SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-17-031769
Filing Date
2017-05-11
Accepted
2017-05-11 09:27:11
Documents
1
Group Members
BPIFRANCE INVESTISSEMENT S.A.S.BPIFRANCE S.A.CAISSE DES DEPOTS ET CONSIGNATIONSEPIC BPIFRANCEFONDS BIOTECHNOLOGIES INNOVANTES ET MALADIES RARES

Document Format Files

Seq Description Document Type Size
1 SC 13G a17-11820_1sc13g.htm SC 13G 170723
  Complete submission text file 0001104659-17-031769.txt   172464
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88266 | Film No.: 17832709
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 56 RUE DE LILLE PARIS I0 75007
Business Address 56 RUE DE LILLE PARIS I0 75007 33158501515
Bpifrance Participations SA (Filed by) CIK: 0001581835 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G